These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25882854)

  • 1. Rab27A regulates transport of cell surface receptors modulating multinucleation and lysosome-related organelles in osteoclasts.
    Shimada-Sugawara M; Sakai E; Okamoto K; Fukuda M; Izumi T; Yoshida N; Tsukuba T
    Sci Rep; 2015 Apr; 5():9620. PubMed ID: 25882854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rab27a and Rab27b are involved in stimulation-dependent RANKL release from secretory lysosomes in osteoblastic cells.
    Kariya Y; Honma M; Hanamura A; Aoki S; Ninomiya T; Nakamichi Y; Udagawa N; Suzuki H
    J Bone Miner Res; 2011 Apr; 26(4):689-703. PubMed ID: 20939018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of tert-butylhydroquinone on osteoclast differentiation via up-regulation of heme oxygenase-1 and down-regulation of HMGB1 release and NFATc1 expression.
    Yamaguchi Y; Sakai E; Sakamoto H; Fumimoto R; Fukuma Y; Nishishita K; Okamoto K; Tsukuba T
    J Appl Toxicol; 2014 Jan; 34(1):49-56. PubMed ID: 23112101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab11A Functions as a Negative Regulator of Osteoclastogenesis through Dictating Lysosome-Induced Proteolysis of c-fms and RANK Surface Receptors.
    Okusha Y; Tran MT; Itagaki M; Sogawa C; Eguchi T; Okui T; Kadowaki T; Sakai E; Tsukuba T; Okamoto K
    Cells; 2020 Oct; 9(11):. PubMed ID: 33142674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coffee diterpene kahweol prevents osteoclastogenesis via impairment of NFATc1 expression and blocking of Erk phosphorylation.
    Fumimoto R; Sakai E; Yamaguchi Y; Sakamoto H; Fukuma Y; Nishishita K; Okamoto K; Tsukuba T
    J Pharmacol Sci; 2012; 118(4):479-86. PubMed ID: 22447306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation.
    Fukuma Y; Sakai E; Nishishita K; Okamoto K; Tsukuba T
    Biofactors; 2015; 41(4):222-31. PubMed ID: 26154488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.
    Yamada N; Tsujimura T; Ueda H; Hayashi S; Ohyama H; Okamura H; Terada N
    Cytokine; 2005 Aug; 31(4):288-97. PubMed ID: 15996478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
    Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
    Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXO1 mediates RANKL-induced osteoclast formation and activity.
    Wang Y; Dong G; Jeon HH; Elazizi M; La LB; Hameedaldeen A; Xiao E; Tian C; Alsadun S; Choi Y; Graves DT
    J Immunol; 2015 Mar; 194(6):2878-87. PubMed ID: 25694609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Punicalagin attenuates osteoclast differentiation by impairing NFATc1 expression and blocking Akt- and JNK-dependent pathways.
    Iwatake M; Okamoto K; Tanaka T; Tsukuba T
    Mol Cell Biochem; 2015 Sep; 407(1-2):161-72. PubMed ID: 26048715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deltamethrin inhibits osteoclast differentiation via regulation of heme oxygenase-1 and NFATc1.
    Sakamoto H; Sakai E; Fumimoto R; Yamaguchi Y; Fukuma Y; Nishishita K; Okamoto K; Tsukuba T
    Toxicol In Vitro; 2012 Sep; 26(6):817-22. PubMed ID: 22634059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.
    Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R
    Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
    Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fyn positively regulates the activation of DAP12 and FcRγ-mediated costimulatory signals by RANKL during osteoclastogenesis.
    Kim HS; Kim DK; Kim AR; Mun SH; Lee SK; Kim JH; Kim YM; Choi WS
    Cell Signal; 2012 Jun; 24(6):1306-14. PubMed ID: 22387224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAMP-2 Is Involved in Surface Expression of RANKL of Osteoblasts In Vitro.
    Jansen IDC; Tigchelaar-Gutter W; Hogervorst JMA; de Vries TJ; Saftig P; Everts V
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.